Snowden Capital Advisors’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.1K Buy
25,379
+970
+4% +$2.8K ﹤0.01% 1322
2026
Q1
$61K Sell
24,409
-4,644
-16% -$15K ﹤0.01% 1265
2025
Q4
$89.5K Hold
29,053
﹤0.01% 1251
2025
Q3
$105K Hold
29,053
﹤0.01% 1221
2025
Q2
$122K Buy
+29,053
New +$114K ﹤0.01% 1189

Other funds holding EVO

Snowden Capital Advisors's EVO Position: Q2 2026 in Review

Snowden Capital Advisors increased its Evotec (EVO) stake by 4% in Q2 2026, buying an estimated $2.8K and bringing the position to 25,379 shares worth $71.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Snowden Capital Advisors first reported a position in EVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $122K in Q2 2025. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • Snowden Capital Advisors held 25,379 shares of Evotec worth $71.1K as of Q2 2026.
  • Snowden Capital Advisors bought 970 Evotec shares in Q2 2026, an estimated $2.8K.
  • Evotec made up ﹤0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #1322 holding.
  • Snowden Capital Advisors first reported a position in Evotec in Q2 2025 and has held it in 5 quarters since.
  • Snowden Capital Advisors's Evotec position peaked at $122K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.